Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022
July 14 2022 - 8:30AM
Royalty Pharma plc (Nasdaq: RPRX) today announced that it will
report its second quarter 2022 financial results on Thursday,
August 4, 2022 before the U.S. financial markets open. The company
will host a conference call and simultaneous webcast at 8:00 a.m.
Eastern Time that day.
Conference Call Information
Please visit the “Investors” page of the company’s website at
https://www.royaltypharma.com/investors/news-and-events/events to
obtain conference call information and to view the live webcast. A
replay of the conference call and webcast will be archived on the
company's website for at least 30 days.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of
biopharmaceutical royalties and a leading funder of innovation
across the biopharmaceutical industry, collaborating with
innovators from academic institutions, research hospitals and
non-for-profits through small and mid-cap biotechnology companies
to leading global pharmaceutical companies. Royalty Pharma has
assembled a portfolio of royalties which entitles it to payments
based directly on the top-line sales of many of the industry’s
leading therapies. Royalty Pharma funds innovation in the
biopharmaceutical industry both directly and indirectly - directly
when it partners with companies to co-fund late-stage clinical
trials and new product launches in exchange for future royalties,
and indirectly when it acquires existing royalties from the
original innovators. Royalty Pharma’s current portfolio includes
royalties on around 35 commercial products, including AbbVie and
Johnson & Johnson’s Imbruvica, Johnson & Johnson’s Tremfya,
Astellas’ and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s Trodelvy,
Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and
Trikafta, and 10 development-stage therapies. For more information,
visit www.royaltypharma.com.
Royalty Pharma Investor Relations and
Communications
+1 (212) 883-6772ir@royaltypharma.com
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Jul 2023 to Jul 2024